Children Consuming High Salt (Sodium) Diet Are At A Higher Risk Of Heart Disease Later In Life
A study on children at the Cincinnati Children's Hospital Medical Center and funded by the National Institutes of Health shows an association between the consumption of a diet with high amounts of salt and increased arterial stiffness (or hardening of arteries) and cardiovascular diseases during adulthood. The arterial stiffness is a known risk factor for stroke and heart attack in adults.
In the current study, researchers recruited 775 participants from the Children's Hospital in Ohio. They measured the brachial artery (BrachD) elasticity. The study tried to find an association between the salt (which contains sodium) consumption with the measurements of brachial artery (BrachD) elasticity.
The study shows higher salt (sodium) consumption is associated with a higher risk of arterial stiffness (higher PWV measurements and lower BrachD). The study accounted for factors such as race, sex, age and body mass index (BMI).
The Centers for Disease Control and Prevention says that adults and teenagers should consume less than 2,300 mg of sodium per day.
The lead author of the study was Dr. Elaine M Urbina, Director, the Cincinnati Children's Hospital Medical Center and the study was presented in the Pediatric Academic Societies 2017 held at San Francisco on May 8, 2017.
Arterial stiffness: Arteriosclerosis and biological aging are the reasons for the arterial stiffness. As arterial stiffness increases, the risk of cardiovascular diseases also increases.
The heartbeat and elastic nature of the arteries can cause the arteries to expand and contract. Blood pressure due to the heartbeat (blood pumping action) will be reduced due to the elastic nature of the arteries. But, the hardening of the arteries (atherosclerosis) can increase the blood pressure.
Regular exercise, no smoking, lower blood pressure, lower cholesterol and lower sugar levels can help an individual in softening of the arteries (called arteriomalacia).
A Predictive Tool For The Detection Of Partial Clinical Remission In Children With Type 1 Diabetes
A team of researchers at University of Massachusetts Medical School (UMMS) have developed a new tool which can predict nonremission of insulin honeymoon phase in children, diagnosed with type 1 diabetes (T1D) with a 73 percent accuracy. The procedure was developed based on measurements of various diabetes-associated autoantibodies and bicarbonate levels in the blood.
This innovative procedure can help doctors and healthcare professionals in identifying those children who require close observation after diagnosis of the type 1 diabetes. The researchers found that 57 percent of the diagnosed type 1 diabetes patients (children or adults) are not getting partial clinical remission phase.
An earlier study shows that those patients who are not getting partial clinical remission may need more insulin in later life and that individual may face health problems related to diabetes in later life.
The author of the study was Dr. Benjamin Nwosu, an associate professor of pediatrics at the University of Massachusetts Medical School (UMMS), Worcester, United States. The study was published in the journal PLOS One. Title of the article is "A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes."
Partial remission: Honeymoon phase or partial remission phase means blood sugar (glucose) levels have been controlled with some insulin secreted by the beta cells in the pancreas. The patient may require additional doses of insulin injections or may not require.
If the HbA1c level of an individual is at 9.0 percent (75 mmol/mol) or less, then one can believe to say that the individual was entered in nonremission of insulin honeymoon or partial remission phase.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.